Yue Shi

ORCID: 0009-0001-6882-2209
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Glycosylation and Glycoproteins Research
  • Helicobacter pylori-related gastroenterology studies
  • Bioinformatics and Genomic Networks
  • interferon and immune responses
  • Galectins and Cancer Biology
  • Ferroptosis and cancer prognosis
  • Circular RNAs in diseases
  • Inflammasome and immune disorders
  • MicroRNA in disease regulation
  • Eicosanoids and Hypertension Pharmacology
  • Cancer-related Molecular Pathways

Tianjin Medical University Cancer Institute and Hospital
2025

Changchun University of Chinese Medicine
2025

Air Force General Hospital PLA
2024

Xuzhou Medical College
2024

Shanxi Province Hospital of Traditional Chinese Medicine
2023

Cancer drug resistance stands as a formidable obstacle in the relentless fight against top five prevalent cancers: breast, lung, colorectal, prostate, and gastric cancers. These malignancies collectively account for significant portion of cancer-related deaths worldwide. In recent years, long non-coding RNAs (lncRNAs) have emerged pivotal players intricate landscape cancer biology, their roles driving are steadily coming to light. This comprehensive review seeks underscore paramount...

10.1016/j.heliyon.2024.e27207 article EN cc-by-nc Heliyon 2024-03-01

Gastric cancer is a leading cause of deaths globally due to its often late diagnosis and poor survival rates. There's an urgent need for reliable non-invasive biomarkers early detection. Claudin-9 (CLDN9), protein implicated in epithelial-mesenchymal transition (EMT), has shown elevated expression various cancers. This study investigates CLDN9's potential as diagnostic marker GC, with particular focus on mitochondrial pathway involvement. The analysis CLDN9 gastric was conducted validated...

10.1007/s12672-025-02153-7 article EN cc-by-nc-nd Discover Oncology 2025-04-08

In the realm of clinical practice, there is currently an insufficiency distinct biomarkers available for detection breast cancer. It utmost importance to promptly employ bioinformatics methodologies investigate prospective cancer, with ultimate goal achieving early diagnosis disease. The initial phase this investigation involved identification 2 cancer gene chips meeting specified criteria within expression omnibus database. Subsequently, paired data analysis was conducted on these datasets,...

10.1097/md.0000000000035273 article EN cc-by-nc Medicine 2023-09-15
Coming Soon ...